(Q39265708)

English

Three types of human CpG motifs differentially modulate and augment immunogenicity of nonviral and viral replicon DNA vaccines as built-in adjuvants

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Three types of human CpG motifs differentially modulate and augment immunogenicity of nonviral and viral replicon DNA vaccines as built-in adjuvants (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

author name string

Yun-Zhou Yu

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Na Li

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Yao Ma

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Shuang Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Wei-Yuan Yu

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Zhi-Wei Sun

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

language of work or name

0 references

publication date

21 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

228-239

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Gene-based vaccines: recent technical and clinical advances

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

DNA vaccines and their applications in veterinary practice: current perspectives

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Vaccine adjuvants: current state and future trends

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

DNA vaccines: recent developments and future possibilities

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Current progress of DNA vaccine studies in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Use of CpG oligodeoxynucleotides as immune adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Enhanced cell-mediated IFN-gamma-secreting activity against the HIV-1IIIB V3 peptide of the TAB9 multiepitope after DNA vaccine backbone engineering

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

CpG motifs are efficient adjuvants for DNA cancer vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Methylated CpG-containing plasmid activates the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

Antiviral protection after DNA vaccination is short lived and not enhanced by CpG DNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

21 January 2018

CpG DNA as a vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG motifs as immune adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of multiple copies of CpG on DNA vaccination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct immune responses of recombinant plasmid DNA replicon vaccines expressing two types of antigens with or without signal sequences

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242690

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201242690

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39265708&oldid=1817337104"